Andersen JK - Search Results

1

Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease.

Rajagopalan S, Rane A, Chinta SJ, Andersen JK. Rajagopalan S, et al. Among authors: andersen jk. J Neurosci. 2016 Jan 27;36(4):1086-95. doi: 10.1523/JNEUROSCI.3117-15.2016. J Neurosci. 2016. PMID: 26818499 Free PMC article.

2

Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?

Rajagopalan S, Andersen JK. Rajagopalan S, et al. Among authors: andersen jk. Mech Ageing Dev. 2001 Sep 30;122(14):1499-510. doi: 10.1016/s0047-6374(01)00283-4. Mech Ageing Dev. 2001. PMID: 11511392 Review.

3

Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.

Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, Yantiri F, Yang L, Beal MF, Andersen JK. Viswanath V, et al. Among authors: andersen jk. J Neurosci. 2001 Dec 15;21(24):9519-28. doi: 10.1523/JNEUROSCI.21-24-09519.2001. J Neurosci. 2001. PMID: 11739563 Free PMC article.

4

Glutathione, iron and Parkinson's disease.

Bharath S, Hsu M, Kaur D, Rajagopalan S, Andersen JK. Bharath S, et al. Among authors: andersen jk. Biochem Pharmacol. 2002 Sep;64(5-6):1037-48. doi: 10.1016/s0006-2952(02)01174-7. Biochem Pharmacol. 2002. PMID: 12213603 Review.

5

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, Andersen JK. Kaur D, et al. Among authors: andersen jk. Neuron. 2003 Mar 27;37(6):899-909. doi: 10.1016/s0896-6273(03)00126-0. Neuron. 2003. PMID: 12670420 Free article.

6

The hunt for a cure for Parkinson's disease.

Andersen JK, Kumar J, Srinivas B, Kaur D, Hsu M, Rajagopalan S. Andersen JK, et al. Sci Aging Knowledge Environ. 2001 Oct 3;2001(1):re1. doi: 10.1126/sageke.2001.1.re1. Sci Aging Knowledge Environ. 2001. PMID: 14602952 Review.

7

Does cellular iron dysregulation play a causative role in Parkinson's disease?

Kaur D, Andersen J. Kaur D, et al. Ageing Res Rev. 2004 Jul;3(3):327-43. doi: 10.1016/j.arr.2004.01.003. Ageing Res Rev. 2004. PMID: 15231240 Review.

8

Iron dysregulation and Parkinson's disease.

Andersen JK. Andersen JK. J Alzheimers Dis. 2004 Dec;6(6 Suppl):S47-52. doi: 10.3233/jad-2004-6s602. J Alzheimers Dis. 2004. PMID: 15665414

9

Dopaminergic neurons.

Chinta SJ, Andersen JK. Chinta SJ, et al. Among authors: andersen jk. Int J Biochem Cell Biol. 2005 May;37(5):942-6. doi: 10.1016/j.biocel.2004.09.009. Epub 2004 Dec 2. Int J Biochem Cell Biol. 2005. PMID: 15743669 Review.

10

Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration.

Kaur D, Rajagopalan S, Chinta S, Kumar J, Di Monte D, Cherny RA, Andersen JK. Kaur D, et al. Among authors: andersen jk. Brain Res. 2007 Apr 6;1140:188-94. doi: 10.1016/j.brainres.2006.03.006. Epub 2006 May 2. Brain Res. 2007. PMID: 16631136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page